Analysts Are Bullish on Top Healthcare Picks

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tactile Systems Technology (NASDAQ: TCMD) and Global Blood Therapeutics (NASDAQ: GBT) with bullish sentiments.

Tactile Systems Technology (NASDAQ: TCMD)

In a report released today, Jason Mills from Canaccord Genuity reiterated a Buy rating on Tactile Systems Technology (NASDAQ: TCMD), with a price target of $46. The company’s shares opened today at $43.23, close to its 52-week high of $44.44.

According to TipRanks.com, Mills is a top 25 analyst with an average return of 26.4% and a 79.2% success rate. Mills covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Staar Surgical Company, and Merit Medical Systems.

Currently, the analyst consensus on Tactile Systems Technology is Strong Buy and the average price target is $40.30, representing a -6.8% downside.

In a report released yesterday, BTIG also maintained a Buy rating on the stock with a $42 price target.

Find more picks by Best Performing Analysts >>

Global Blood Therapeutics (NASDAQ: GBT)

Cowen & Co. analyst Ritu Baral maintained a Buy rating on Global Blood Therapeutics (NASDAQ: GBT) today and set a price target of $83. The company’s shares opened today at $48.80.

According to TipRanks.com, Baral is a top 25 analyst with an average return of 34.3% and a 55.9% success rate. Baral covers the Healthcare sector, focusing on stocks such as Madrigal Pharmaceuticals Inc, ACADIA Pharmaceuticals Inc, and Allena Pharmaceuticals Inc.

Currently, the analyst consensus on Global Blood Therapeutics is Strong Buy and the average price target is $72.88, representing a 49.3% upside.

In a report issued on May 1, William Blair also maintained a Buy rating on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.